191 related articles for article (PubMed ID: 37879293)
1. Hyperemesis gravidarum and the risk of childhood cancer - A case-control study in Denmark.
Orimoloye HT; Deng C; Hansen J; Olsen J; Saechao C; Ritz B; Heck JE
Cancer Epidemiol; 2023 Dec; 87():102472. PubMed ID: 37879293
[TBL] [Abstract][Full Text] [Related]
2. Hyperemesis gravidarum and risk of cancer in offspring, a Scandinavian registry-based nested case-control study.
Vandraas KF; Vikanes ÅV; Støer NC; Troisi R; Stephansson O; Sørensen HT; Vangen S; Magnus P; Grjibovski AM; Grotmol T
BMC Cancer; 2015 May; 15():398. PubMed ID: 25963309
[TBL] [Abstract][Full Text] [Related]
3. Long-term health outcomes of children born to mothers with hyperemesis gravidarum: a systematic review and meta-analysis.
Nijsten K; Jansen LAW; Limpens J; Finken MJJ; Koot MH; Grooten IJ; Roseboom TJ; Painter RC
Am J Obstet Gynecol; 2022 Sep; 227(3):414-429.e17. PubMed ID: 35367190
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of hyperemesis gravidarum for nonsyndromic oral clefts.
Czeizel AE; Sárközi A; Wyszynski DF
Obstet Gynecol; 2003 Apr; 101(4):737-44. PubMed ID: 12681879
[TBL] [Abstract][Full Text] [Related]
5. Perinatal outcomes of infants born to mothers with hyperemesis gravidarum: A systematic review and meta-analysis.
Jansen LAW; Nijsten K; Limpens J; van Eekelen R; Koot MH; Grooten IJ; Roseboom TJ; Painter RC
Eur J Obstet Gynecol Reprod Biol; 2023 May; 284():30-51. PubMed ID: 36924660
[TBL] [Abstract][Full Text] [Related]
6. Maternal vomiting during early pregnancy and cardiovascular risk factors at school age: the Generation R Study.
Poeran-Bahadoer S; Jaddoe VWV; Gishti O; Grooten IJ; Franco OH; Hofman A; Steegers EAP; Gaillard R
J Dev Orig Health Dis; 2020 Apr; 11(2):118-126. PubMed ID: 31474237
[TBL] [Abstract][Full Text] [Related]
7. Safety and effectiveness of Japanese herbal Kampo medicines for treatment of hyperemesis gravidarum.
Michihata N; Shigemi D; Sasabuchi Y; Matsui H; Jo T; Yasunaga H
Int J Gynaecol Obstet; 2019 May; 145(2):182-186. PubMed ID: 30734286
[TBL] [Abstract][Full Text] [Related]
8. Hyperemesis gravidarum and maternal cancer risk, a Scandinavian nested case-control study.
Vandraas KF; Grjibovski AM; Støer NC; Troisi R; Stephansson O; Ording AG; Vangen S; Grotmol T; Vikanes ÅV
Int J Cancer; 2015 Sep; 137(5):1209-16. PubMed ID: 25665163
[TBL] [Abstract][Full Text] [Related]
9. Determinants of hyperemesis gravidarum among pregnant women attending antenatal care at public and private hospitals in Bahir Dar City, North-West Ethiopia, 2022: a multicenter unmatched case control study.
Asrade L; Misikir D; Alemu H; Belachew A; Almaw H
BMC Womens Health; 2023 May; 23(1):225. PubMed ID: 37138281
[TBL] [Abstract][Full Text] [Related]
10. Maternal anemia and childhood cancer: a population-based case-control study in Denmark.
Qureshi N; Orimoloye H; Hansen J; Saechao C; Olsen J; Federman N; Huang X; He D; Ritz B; Heck JE
Cancer Epidemiol; 2023 Feb; 82():102308. PubMed ID: 36434977
[TBL] [Abstract][Full Text] [Related]
11. Interventions for treating hyperemesis gravidarum.
Boelig RC; Barton SJ; Saccone G; Kelly AJ; Edwards SJ; Berghella V
Cochrane Database Syst Rev; 2016 May; 2016(5):CD010607. PubMed ID: 27168518
[TBL] [Abstract][Full Text] [Related]
12. Recurrence patterns of hyperemesis gravidarum.
Nurmi M; Rautava P; Gissler M; Vahlberg T; Polo-Kantola P
Am J Obstet Gynecol; 2018 Nov; 219(5):469.e1-469.e10. PubMed ID: 30121224
[TBL] [Abstract][Full Text] [Related]
13. Incidence and risk factors of hyperemesis gravidarum: A national register-based study in Finland, 2005-2017.
Nurmi M; Rautava P; Gissler M; Vahlberg T; Polo-Kantola P
Acta Obstet Gynecol Scand; 2020 Aug; 99(8):1003-1013. PubMed ID: 32030718
[TBL] [Abstract][Full Text] [Related]
14. Hyperemesis Gravidarum and the Potential for Cancer: A Longitudinal Cohort Study over Three Decades.
Marcoux S; Leduc V; Healy-Profitós J; Bilodeau-Bertrand M; Auger N
Cancer Epidemiol Biomarkers Prev; 2022 Oct; 31(10):1919-1925. PubMed ID: 35839462
[TBL] [Abstract][Full Text] [Related]
15. Exposure to nitrosatable drugs during pregnancy and childhood cancer: A matched case-control study in Denmark, 1996-2016.
Sirirungreung A; Hansen J; He D; Huang X; Ritz B; Heck JE
Pharmacoepidemiol Drug Saf; 2023 Apr; 32(4):496-505. PubMed ID: 36300575
[TBL] [Abstract][Full Text] [Related]
16. Relationship between hyperemesis gravidarum and small-for-gestational-age in the Japanese population: the Japan Environment and Children's Study (JECS).
Morokuma S; Shimokawa M; Kato K; Sanefuji M; Shibata E; Tsuji M; Senju A; Kawamoto T; Kusuhara K;
BMC Pregnancy Childbirth; 2016 Aug; 16(1):247. PubMed ID: 27561599
[TBL] [Abstract][Full Text] [Related]
17. The sex ratio of pregnancies complicated by hospitalisation for hyperemesis gravidarum.
Schiff MA; Reed SD; Daling JR
BJOG; 2004 Jan; 111(1):27-30. PubMed ID: 14687048
[TBL] [Abstract][Full Text] [Related]
18. Hyperemesis gravidarum and risks of placental dysfunction disorders: a population-based cohort study.
Bolin M; Åkerud H; Cnattingius S; Stephansson O; Wikström AK
BJOG; 2013 Apr; 120(5):541-7. PubMed ID: 23360164
[TBL] [Abstract][Full Text] [Related]
19. Original article: is the protective association between hyperemesis gravidarum and birth defects biased by pregnancy termination?
Boissière-O'Neill T; Schnitzer ME; Lewin A; Bilodeau-Bertrand M; Ayoub A; Auger N
Ann Epidemiol; 2021 Jul; 59():10-15. PubMed ID: 33798708
[TBL] [Abstract][Full Text] [Related]
20. Interventions for treating hyperemesis gravidarum: a Cochrane systematic review and meta-analysis.
Boelig RC; Barton SJ; Saccone G; Kelly AJ; Edwards SJ; Berghella V
J Matern Fetal Neonatal Med; 2018 Sep; 31(18):2492-2505. PubMed ID: 28614956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]